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Antibodies raised in Indian rhesus macaques [Macaca mulatta (MM)] in many preclinical
vaccine studies are often evaluated in vitro for titer, antigen-recognition breadth, neutralization potency, and/or effector function, and in vivo for potential associations with
protection. However, despite reliance on this key animal model in translation of promising
candidate vaccines for evaluation in first in man studies, little is known about the properties of MM immunoglobulin G (IgG) subclasses and how they may compare to human IgG
subclasses. Here, we evaluate the binding of MM IgG1, IgG2, IgG3, and IgG4 to human
Fc gamma receptors (FcγR) and their ability to elicit the effector functions of human
FcγR-bearing cells, and unlike in humans, find a notable absence of subclasses with
dramatically silent Fc regions. Biophysical, in vitro, and in vivo characterization revealed
MM IgG1 exhibited the greatest effector function activity followed by IgG2 and then
IgG3/4. These findings in rhesus are in contrast with the canonical understanding that
IgG1 and IgG3 dominate effector function in humans, indicating that subclass-switching
profiles observed in rhesus studies may not strictly recapitulate those observed in human
vaccine studies.
Keywords: IgG, rhesus, effector function, non-human primate, Fc receptor

INTRODUCTION
Studies in non-human primates (NHP) are often a key aspect of preclinical vaccine development.
Antibodies raised in NHP in such studies are often evaluated in vitro for titer, antigen-recognition
breadth, and neutralization potency or effector function, as well as in vivo for potential associations
with protection. These studies are conducted in settings ranging from simian immunodeficiency
virus (SIV) or simian/human immunodeficiency virus, to TB, yellow fever, dengue, and malaria,
among many others, with a goal of evaluating and understanding vaccine-mediated protection (1).
However, despite reliance on NHP in translation of promising candidate vaccines and the established significance of antibody interactions with Fc gamma receptors (FcγR) as key contributions to
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antibody activity in vivo, little is known about the properties of
NHP immunoglobulin G (IgG) subclasses. The widespread use
of NHP in preclinical studies aimed at evaluating the possible
efficacy of candidate vaccines, and the accumulating evidence
that Fc-dependent activities strongly contribute to antibodymediated protection, encourages functional characterization of
IgG subclasses in these crucial model organisms.
For example, Indian rhesus macaques [Macaca mulatta
(MM)] have been used extensively for evaluating antibody-based
correlates of vaccine-mediated protection, and in several studies, antibody effector functions have been implicated as critical
components of protection against SIV infection (2–5). However,
despite these associations with protective efficacy, little is known
about the functional characteristics of MM IgG subclasses.
Reliance on these animal models in evaluation of candidate
vaccines dictates closer evaluation of NHP IgG immunobiology, as despite evolutionary proximity, there may be important
immunological differences between species.
In humans, antibody responses associated with differential
IgG subclass compositions across different pathogen or antigen
types are well known, and in some cases protection or pathology
has been found to associate with variation in subclass selection.
While a number of studies have investigated IgG subclasses
in NHP (6, 7), the majority of this effort has been directed at
defining subclass sequences; despite small study cohort sizes,
this work has suggested significant allotypic diversity in IgA
(8, 9). Previous experimental work has begun to elucidate the
landscape of antibody properties in NHP but has not converged
to yield a consensus understanding of the functions of primate
IgG subclasses. Perplexingly, in an early experimental study
aimed at functional characterization of cynomolgus macaque
IgG subclasses, investigators observed similar subclass activities as in human (10), while a more recent investigation found
divergent activity profiles between human and macaque IgG
subclasses (11).
Here, we seek to evaluate the functional activity of MM IgG
subclasses with the aim of enabling comparison of immunoglobulin biology between species. Evaluating species-mismatched
antibodies and receptors is also relevant to the widespread use
of human effector cells to evaluate the potency of rhesus serum
IgGs elicited in vaccine studies, in which effector functions
such as antibody-dependent cellular cytotoxicity (ADCC) (2, 5,
12–15), virus inhibition (ADCVI) (12, 16, 17), or phagocytosis
(ADCP) (5, 15, 18) activities are often determined. These in vitro
data help inform the potential mechanistic contributions of
effector function to in vivo observations of protection or viremic
control during vaccination or passive transfer studies in the NHP
model and enable insight into vaccine and therapeutic design for
humans. As a practical matter, the use of rhesus peripheral blood
mononuclear cells (PBMCs) in effector assays is avoided due to
their high inherent natural killer (NK) lytic activity and capacity
to kill SIV-infected target cells. As a result, despite the species
mismatch, the use of human target cells and human PBMCs in
assessing the functional quality of rhesus antibody responses is
specifically advised (2, 12, 19).
The use of human cell lines or PBMCs has enabled simple,
reliable, and highly sensitive assays to assess rhesus macaque IgG
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effector functions and has eased comparison to in vivo results or
to the in vitro functional activity of human IgGs. For example,
the human PBMC ADCC activity of vaccine-elicited, serumderived rhesus IgG has correlated to reduced acute viremia after
intravaginal (2) and intrarectal (13) challenge with pathogenic
SIV in vivo. Both ADCC and ADCVI assays using human PBMCs
with rhesus anti-SIV IgG have been used to assess Ab potency in
passive transfer studies (12). Additionally, the use of the human
monocytic THP-1 cell line has been used to differentiate the
phagocytic potential of vaccine-elicited rhesus serum IgG (18).
Most importantly, such species-mismatched functional evaluations of antibody activity have correlated with protection from
viral infection in recent challenge studies (5, 15).
Despite the prevalence of leveraging human effector cells to
analyze the functionality of rhesus IgGs in vaccine and passive
transfer studies, there is little known about the biophysical
characteristics of rhesus IgG interacting with human FcγR. Here,
we characterize the ability of recombinant rhesus IgG1, IgG2,
IgG3, and IgG4 to interact with human FcγR and to induce the
effector functions of human FcγR-bearing innate immune cells in
order to investigate differences and similarities between species
in terms of IgG subclass biology. As interspecies and intraspecies
differences in IgG sequence and function pose potential caveats
to the translation of findings in these key animal models, better
understanding of antibody immunobiology in primates may
prove key to enhancing the design and evaluation of future vaccine candidates.

MATERIALS AND METHODS
Construction, Expression, and
Purification of IgG and FcγR

To construct reference MM IgG of different subclasses, total RNA
was isolated from 106 mouse hybridoma cells expressing antiCD8α monoclonal antibody, M-T807 (20) using RNAqueous4PCR kit (Ambion Inc., Austin, TX, USA). A cDNA library
was produced using SMARTer™ RACE cDNA Amplification
Kit (Clontech, Mountain View, CA, USA). DNA encoding the
variable domains of the heavy (VH) and the light chain (VL)
were amplified using Advantage 2 PCR Kits (Clontech) with
IgG1H (5′-ACCAAC GCTGCAGGTGACGGTCTGAC-3′) and
IgG1k (5′-CTAACACTCATTCCTGTTGAAGCTCTTGAC-3′),
cloned into the pCR 2.1-TOPO vector, used to transform One
Shot TOP10 Chemically Competent E. coli (Invitrogen), and
sequences confirmed. Three different rhesus recombinant
versions of M-T807 were developed by grafting the CDRs, as
defined by Kabat et al. (21), using rhesus Ig germline variable
region sequences (NCBI accession numbers XP_0010960271 and
XP_0011060902) as templates. Key positions potentially contributing to antigen binding, CDR conformation, and heavy–light
chain interactions were back-mutated to the mouse residues.
DNA representing recombinant VH and VL were subcloned into
1
2

2

http://www.ncbi.nlm.nih.gov/protein/XP_001096027.2.
http://www.ncbi.nlm.nih.gov/protein/XP_001106090.1.

December 2016 | Volume 7 | Article 589

Boesch et al.

Characterization of Rhesus Macaque IgG Subclasses

expression vectors containing rhesus IgG1 heavy chain (CH) and
rhesus kappa light chain (CL) constant regions cloned from a
rhesus B-lymphoblastoid cell line by PCR amplification. Rhesus
recombinant antibodies representing each H + L chain combination were transiently expressed at small scale in HEK293 cells by
co-transfection of recombinant light and heavy chain expression
vectors using Lipofectamine (Invitrogen) and purified by Protein
A affinity chromatography (GE Health Care). The CDR-grafted
H + L chain pair that yielded the highest relative affinity antibody
measured using a CD8α-expressing cell-based ELISA assay was
used for all further experiments. The CDR-grafted VH segments
were also subcloned into rhesus IgG2, IgG3, or IgG4 CH expression vectors, using rhesus gamma chain sequences previously
reported (9), to permit expression of rhesus recombinant antibody
of different IgG subclasses but sharing identical variable regions.
For large-scale production of rhesus antibodies, recombinant
heavy and light chain vectors were packaged in retroviral vectors
and used to infect CHO cells using the GPEx™ expression platform (Catalent Pharma Solutions, Madison, WI, USA). A pool of
transduced cells was grown in serum-free medium from which
recombinant antibodies were purified by protein A affinity chromatography and formulated in phosphate buffer at pH 6.5–8.0,
based on each antibody’s isoelectric point. Endotoxin levels were
<1 EU/mg of antibody. Recombinant rhesus antibody samples
used in binding assays were SEC purified until aggregated IgG
was undetectable (i.e., less than one part per thousand), and the
monomeric fraction was used for all studies with the exception of
IgG samples used in deglycosylation experiments.
Pooled polyclonal rhesus IgG purified from serum was
obtained from the NHP Reagent Resource, and IgG from rhesus
serum from a set of 47 Indian-origin rhesus macaques was evaluated either following dilution or after depletion of other common serum proteins using Melon gel (Thermo Pierce). Human
IgG1, IgG2, and IgG4 myeloma proteins were obtained from
Athens Research Corporation, while IgG3 myeloma protein was
obtained from Sigma-Aldrich. The purity of these commercial
preparations was described as >90%. The human VRC01 mAb
was subclass-switched into IgG2, IgG3, and IgG4 forms as follows.
Human IgG subclass backbone plasmids were obtained from
Invivogen (pFUSEss-CHIg-hG2, pFUSEss-CHIg-hG3, pFUSEssCHIg-hG4). The entire VRC-01 variable region was cloned out of
the parent pCMV VRC01 IgG1 HC plasmid (NIH AIDS Reagent
Program) and inserted into each individual subclass backbone
plasmid. Sequencing was performed to confirm variable region
insertion. Subsequently, each VRC-01 subclass gene was cloned
back into an empty pCMV plasmid to maximize dual expression
of the heavy chain with the pCMV VRC01 IgG1 LC plasmid (NIH
AIDS Reagent Program).
The glycosylation profile of recombinant MM IgG subclasses
and of polyclonal, serum-derived MM IgG was determined by
HPLC as previously described (22). Human FcγRs were expressed
and purified as previously described (23).

screened for species and subclass specificity, resulting in isolation of a clone (7H11) with good specificity for MM IgG1, and
minor recognition of MM IgG3. In order to generate monoclonal antibodies specific for MM IgG2 and IgG3, mice were
immunized with peptides derived from the IgG hinge region,
where MM subclasses demonstrate significant differences. The
overlapping peptides VVHEPSNTKVDKTVGLPCRSTCPPCP
and
DKTVGLPCRSTCPPCPAELLGCPSVF
were
used
to generate anti-IgG2 responses, whereas the peptide
DKRVEFTPPCGDTTPPCPPPCPP was used to generate antiIgG3 responses. Resulting antibodies were extensively screened
for specificity and sensitivity, and clones 3C10 (anti-MM IgG2)
and 2G11 (anti-MM IgG3) were identified. Similar approaches
to immunize mice with IgG4 hinge peptides failed to generate
monoclonal antibodies that bound specifically to MM IgG4. All
reference IgGs and anti-subclass detecting antibodies are available through the NHP Reagent Resource.

Structure Visualization and Manipulation

Immunoglobulin G alignments were generated using Geneious
and ClustalW2. Sequences and coordinates for human IgG1 in
complex with FcγRIIIb were retrieved from the Protein Data
Bank (PDB) entry 1T89. FcγRI (PDB 4W4O) was aligned to
FcγRIIIb (PDB 1T89), and contact residues were determined
from the combined model using a cutoff distance of 5 Å. All
structure manipulations and visualizations were performed in
Chimera version 1.10.1 (24). Macaque sequences were retrieved
from Scinicariello et al. (9), and human IgG sequences were
from Uniprot P01857, P01859, P01860, and P01861. ClustalW2
alignments were used in Chimera to render by conservation. All
protein structures shown are from 1T89 only.

EndoS and PNGase F Treatment of IgG

For EndoS treatment of IgGs, 100 µg of MM monoclonal IgGs
(NHP Reagent Resource) were treated with 2 µg of 1 mg/mL
EndoS (gift from Dr. Kavitha Baruah from Oxford University)
overnight at 37°C. EndoS is an enzyme from S. pyogenes that is
highly specific for cleaving the IgG Fc glycan following the initial
variably fucosylated N-acetylglucosamine (25). EndoS in the
samples were inactivated by incubation at 55°C for 10 min. For
PNGase F treatment of IgGs (to remove the entire Fc glycan),
0.5 µL of Remove-iT PNGase F (NEB) was added to each 100 µg
sample of IgG and incubated for 24 h at 37°C. The PNGase F
was then removed using chitin magnetic beads according to the
protocol provided by New England Biolabs. Glycan removal was
confirmed by running 2 µg of each DTT reduced IgG sample
on a 4–12% bis-tris gel and observing a 3-kDa decrease in the
molecular weight for the IgG heavy chain. Further confirmation
was provided by lectin western blot (data not shown).

Multiplex IgG Subclassing and Human
FcγR Binding Assay

MM Anti-Subclass Detection Reagents

Purified, monomeric Hu FcγR or subclass-specific MM IgG detection reagents (7H11, 3C10, 2G11 clones, NHP Reagent Resource)
were coupled to carboxylated magnetic beads (Luminex Corp.)
using amine reactive chemistry as described previously (26). In

A set of anti-MM IgG subclass detection monoclonal antibodies was developed as follows. Mice were immunized with
baboon (P. anubis) serum IgG, and resulting hybridomas were
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an adaptation of a previously described protocol (23), antibody
samples were serially diluted in 0.05% Tween-PBS in non-binding,
clear-bottom black 384 well plates (Corning) in a total volume
of 40 µL and for every dilution series, an additional well lacking
test antibody was evaluated to determine background signal. A
master bead mix containing all the receptor detection bead sets
of interest was prepared in 0.05% Tween-PBS at a concentration
of 50,000 beads/mL for each bead set. A 10-µL volume of this
master bead mix was added to each well-containing antibody
sample to reach a final volume of 50 µL. The plate was sonicated
for 10–20 s to mix and then placed on an XYZ plate shaker (IKA)
at 800 rpm for 2 h at room temperature. Unbound antibody was
removed by washing the plate using an automatic plate washer
(Biotek) fitted with a plate magnet and programed to conduct
five washes with 60 µL of 0.05% Tween-PBS. Next, 40 µL of a
0.65 µg/mL goat anti-rhesus heavy and light chain-PE (Southern
Biotech) in 0.05% Tween-PBS solution was added to each well,
and the plate was sonicated and shaken at 800 rpm at room
temperature for 1 h. The plate was washed again, and 35 µL of
sheath fluid was used to resuspend beads in each well for analysis
on a FlexMap 3D (Luminex Corp.). At least 35 beads for each
bead set were analyzed. The average background MFI signal from
wells that lacked antibody was subtracted from the signal from
antibody-containing wells to account for any non-specific binding of detection reagent to beads. For all detection reagents, the
magnitude of fluorescence observed from non-specific binding of
detection reagent to the beads was comparable to that when beads
are run in the absence of detection reagent (data not shown).
Background-subtracted data were analyzed in GraphPad Prism,
and non-linear regression trend lines were fit using the one site,
specific binding model.

to development and absorbance measurements, essentially as
described. Data were analyzed in GraphPad Prism, and nonlinear regression trend lines were fit using the one site, specific
binding model.

LC–MS/MS Analysis of IgG Subclasses

Macaca mulatta serum from Indian-origin rhesus macaques and
individual and defined mixtures of recombinant IgG subclass
standards were reduced and separated by SDS-PAGE. Briefly,
10 µL of reduced and alkylated sample, at an estimated (serum)
or exact (recombinant) IgG concentration of 0.167 mg/mL, was
loaded into individual wells of a 15-well NuPAGE 4–12% bistris gel (ThermoFisher) and run at 200 V for 45 min, followed by
visualization with Coomassie blue stain, band excision of the IgG
HC, and in-gel digestion per standard procedures with sequencing grade trypsin (Promega). Peptide digests were analyzed by
online microcapillary LC–MS/MS using an EasyLC-1000 UPLC
and Q Exactive Plus mass spectrometer platform. Peptides
were resuspended in 5% methanol/1% formic acid and loaded
on to a trap column [1 cm length, 100 µm inner diameter,
ReproSil, C18 AQ 5 µm 120 Å pore (Dr. Maisch, Ammerbuch,
Germany)], vented to waste via a micro-tee, and eluted across
a fritless analytical resolving column (35 cm length, 100 µm
inner diameter, ReproSil, C18 AQ 3 µm 120 Å pore) pulled
in-house (Sutter P-2000, Sutter Instruments, San Francisco,
CA, USA) with a 60-min gradient of 5–30% LC-MS buffer B
(LC-MS buffer A: 0.0625% formic acid, 3% ACN; LC-MS buffer
B: 0.0625% formic acid, 95% ACN). The Q Exactive Plus was set
to perform an Orbitrap MS1 scan (R = 70 K; AGC target = 3e6)
from 350 to 1,500 Th, followed by HCD MS2 spectra on the 10
most abundant precursor ions detected by Orbitrap scanning
(R = 17.5 K; AGC target = 1e5; max ion time = 75 ms) before
repeating the cycle. Precursor ions were isolated for HCD by
quadrupole isolation at width = 0.8 Th and HCD fragmentation
at 26 normalized collision energy. Charge state 2, 3, and 4 ions
were selected for MS2. Precursor ions were added to a dynamic
exclusion list ± 20 ppm for 20 s. Raw data were searched using
COMET (release version 2014.01) in high resolution mode (27)
against a FASTA database containing all four IgG subclasses
with a precursor mass tolerance of ±1 Da and a fragment ion
mass tolerance of 0.02 Da, and requiring fully tryptic peptides
(K, R; not preceding P) with up to three miscleavages. Static
modifications included carbamidomethylcysteine, and oxidized
methionine was the variable modification. Searches were filtered using orthogonal measures including mass measurement
accuracy (±3 ppm), Xcorr for charges from +2 through +4, and
dCn targeting a <1% FDR at the peptide level. Quantification
of LC–MS/MS spectra was performed using MassChroQ (28).
Annotated spectra and details of the peptides observed for
each sample are provided in Files S1 and S2 in Supplementary
Material, respectively.

ELISA Subclassing Assays

Specificity of MM anti-subclass detection antibodies was
evaluated by ELISA, in which plates were functionalized with the
extracellular domain of rhesus macaque CD8α protein, incubated
with the recombinant anti-CD8α MM IgGs, and detected by
the anti-subclass detection reagents. ELISA plates were coated
overnight at 4°C with 0.5 µg/mL goat anti-HIS tag monoclonal
antibody diluted in carbonate–bicarbonate buffer, pH 9.0, then
blocked with Superblock at room temperature for 45 min.
Recombinantly expressed and purified rhesus CD8α-HIS (NHP
Reagent Resource) was applied at 5 µg/mL in 2% BSA for 1 h.
Monoclonal anti-rhesus CD8α antibodies (IgG1–4) were applied
for 1 h at 10 µg/mL in 2% BSA. Bound MM IgG was detected
using the anti-rhesus IgG subclassing reagents described above
diluted to 20 µg/mL in 2% BSA over a fourfold serial dilution
range. After incubation for 1 h, bound subclass detection reagents
were detected using a 1:1,000 dilution of a goat anti-mouse IgG
(H + L) HRP in 2% BSA for 1 h, which was visualized with peroxidase substrate after a 4-min incubation at room temperature prior
to stopping and reading out the product formation at OD 450 nm.
The presence of each IgG subclass in a single, pooled MM
serum sample was evaluated similarly, with the exception that
each recombinant MM IgG subclass and a MM serum sample
were adhered directly to ELISA plates, followed by incubation
with anti-subclass detection reagents over a dilution curve prior
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Surface plasmon resonance was used to measure equilibrium
binding affinities. A Continuous Flow Microspotter (CFM)
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of 200 µL. On each plate, two blocked wells received 2.5 μg/mL
PMA and 0.5 µg/mL ionomycin as positive controls, while two
blocked wells containing no antibody or cell stimulant served
as negative controls. Following an 1-h incubation of the plates
under 37°C, 5% CO2 conditions, Brefeldin A (final concentration
of 10 µg/mL) and mononensin (GolgiStop, final concentration of
6 µg/mL) were added to each well and the plates incubated for
another 3–5 h. After incubation, cells were washed with cold PBS,
pelleted at 400 × g in a chilled (4°C) centrifuge, and resuspended
in fixative prepared in PBS. Fixation of cells occurred during a
15-min, room temperature incubation that was shielded from
light, and the reaction was subsequently quenched using PBS
containing 5% serum protein. The quenching buffer was used for
a final wash before resuspension in PBSF (PBS + 0.1% BSA). Data
were acquired on a MACSQuant flow cytometer and analyzed
using Flowjo V10 and GraphPad Prism. Non-linear regression
trend lines were fit using the one site, specific binding model.
ADCC assays were repeated five times, either in duplicate or
triplicate.

(Wasatch Microfluidics) was used to print up to 96 individual regions of interests (ROI) on a single gold prism surface
coated with carboxymethyldextran substrate (200 M Xantec
Bioanalytics). CFM fluid paths were primed with 25 mM sodium
acetate pH 5.0 + 0.01% Tween 20 prior to activation. The substrate
of each ROI was activated for 5–7 min with 100 µL of 1.2 mM
N-hydroxysulfosuccinimide (sNHS) (Pierce) and 0.3 mM
1-ethyl-3-[3 dimethlyaminopropyl]carbodiimide-HCl (EDC)
(Pierce) in deionized water under flow at 45 µL/min. Antibodies
prepared at 50, 25, 12.5, and 6.25 µg/mL in 25 mM sodium acetate
pH 4.5–5.0 and printed on the activated ROI at the four resulting
ligand (IgG) densities. A direct IgG coupling method was used
since a suitable rhesus-specific capture reagent with a sufficiently
slow off rate across all rhesus IgG subclass could not be identified. The image-based array reader (MX96, IBIS Technologies)
was primed with 25 mM sodium acetate pH 5.0 + 0.01% Tween
20 and the prism loaded and quenched with 120 µL of 0.5 M
ethanolamine (Sigma-Aldrich) prior to priming, conditioning,
and analyte injections. FcγRs were diluted in running buffer
(PBS + 0.01% BSA + Tween 20) and injected over an eight part,
threefold serial dilution series, generally starting between 18 and
41 µM, and consisting of the following steps: 0.5-min baseline,
5-min association, 5-min dissociation, and 0.5-min baseline. The
prism was regenerated with 0.5 min 100 mM glycine pH 3.0 and
0.5 min baseline between each analyte (FcγR) dilution tested. ROI
signal was double referenced using signal from blank injections
and signal from uncoupled interspots to account for non-specific
binding. Data were processed in Scrubber 2 (Biologic Software
Ltd.) by kinetic analysis applying global analysis to determine the
equilibrium dissociation constant, KD. Steady-state analysis to
calculate KD yielded similar values. Genetically and enzymatically
deglycosylated human IgG1 and a panel of mAbs and Fc point
mutants were used as controls and recapitulated the expected
patterns of FcγR recognition preferences (data not shown).
Experiments were repeated 2 to 12 times with different conjugation densities and print pH conditions. Data from two separate
experiments using different preparations of FcγRs, each with
multiple print spots for each IgG sample are presented.

Antibody-Dependent Cellular Phagocytosis

The phagocytic activity of human myeloma and MM IgG
subclasses was assessed by adaptation of previously described
phagocytosis assay (33). Briefly, 1 µm, yellow–green fluorescent FluoSpheres® Carboxylate-Modified Microspheres (Life
Technologies) were conjugated with rhesus CD8α extracellular
domain protein (NHP Reagent Resource, NIH, MM IgG subclass
apparent affinity ranged 1.2- to 1.4-fold across subclasses) for
evaluation of MM subclasses, or anti-human IgG Fab (Jackson
Immunoresearch, human IgG subclass apparent affinity ranged
1.2- to 2.5-fold across subclasses) for analysis of human myelomaderived subclasses, and diluted to 800,000 beads per 50 µL in
RPMI 1640 with l-glutamine (Corning), 10% FBS (Biowest),
and 1× Penicillin/Streptomycin/Amphotericin (Corning). The
THP-1 human monocyte cell line (gift from Dr. Brent Berwin)
was used as the effector cell population, and cells were diluted to
20,000 cells per 150 µL RPMI. The assay was run in a 96-well tissue culture plate by pipetting 50 μL of beads, then 150 µL of cells,
and lastly 50 µL of RPMI alone or antibody diluted in RPMI at 5×
the final target concentration. The cells were incubated at 37°C at
5% CO2 for 4 h. After incubation, cells were fixed as described for
the degranulation assay. Data were acquired on a MACSQuant
flow cytometer and analyzed using Flowjo V10. A backgroundsubtracted phagocytosis score was calculated by multiplying
the percentage of bead positive cells by their MFI, followed by
subtraction of the phagocytosis score observed in the absence of
antibody. Data were analyzed in GraphPad Prism, and non-linear
regression trend lines were fit using the one site, specific binding
model. ADCP assays were repeated five times, either in duplicate
or triplicate. Equivalent opsonization of beads with each subclass
was experimentally confirmed.

In Vitro Functional Assays
Natural Killer Cell Degranulation

The ADCC potential of MM IgG subclasses was assessed by an
adaptation of previously described assays (29, 30) in which NK
cell degranulation is measured based on CD107a surface expression, a marker correlated with human NK cell cytokine release,
cytotoxic activity (29), and ADCC, in the presence of human
IgGs (31, 32) as well as rhesus macaque serum samples (14). The
NK-92 human NK cell line (NantKwest, formerly Conkwest) was
cultured in tissue culture flasks at 37°C, 5% CO2, with passaging
every 3–4 days from 50 to 600,000 cell/mL using RPMI 1640 supplemented with l-glutamine, horse, and bovine sera, 100 U/mL
IL-2 (AIDS Reagent Resource), and MEM non-essential amino
acids. Sterile, 96-well polystyrene plates (Costar) were coated
overnight at 4°C with a dilution series of each test IgG, diluted
in PBS. Plates were washed and blocked using 1% BSA in PBS at
room temperature. Each well received 2–10 × 103 and 0.2 test volumes of anti-human CD107a detection reagent in a total volume
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In Vivo Depletion Activity

Antibody Administration to Animals

Indian rhesus monkeys (MM) were administered a single
50 mg/kg dose of recombinant MM IgG anti-CD8α antibodies
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comprising the four MM IgG subclasses by intravenous injection. Blood samples were periodically drawn to assess the effect
of each subclass on depletion of CD8+ lymphocytes. For all
injections and blood sampling, animals were anesthetized with
ketamine HCl. All animals were maintained in accordance with
the guidelines of the Committee on Animals for the Harvard
Medical School and the Guide for the Care and Use of Laboratory
Animals (34).

of substitutions are present in or adjacent to contact residues
(Figure 1A), particularly among those at the start of the CH2
domain near the hinge. Visualization of these sites of human
subclass variation is consistent with their well-characterized
differences in FcγR recognition (Figure 1D). In contrast, when
MM subclasses are compared to each other, there are relatively
fewer and generally more conservative substitutions at the
interface (Figures 1E,F). However, several substitutions might
be expected to impact FcγR recognition. First, MM IgG2 has a
deletion of P2, proximal to FcγR contact residues. Second, MM
IgG3 and IgG4 possess an A97G substitution in an FcγR contact
residue. Interestingly, the A97G substitution is also present in
human IgG2 and IgG4. Overall, structural assessment of sites
of variation also suggests that MM subclass activities might
be expected to vary less considerably than their human IgG
counterparts.

Lymphocyte Immunophenotyping

Lymphocytes in peripheral blood were immunophenotyped
using EDTA-anticoagulated blood specimens in a whole blood
lysis technique. Fluorochrome-conjugated antibodies were
incubated with 100 µL of whole blood or lymph node cell suspension for 20 min at room temperature. Antibodies used were
anti-CD3 (SP34)-APC, anti-CD4-FITC (L200) (BD Bioscience),
and anti-CD8-PE (DK25, Dako, Inc., Carpenteria, CA, USA).
Erythrocytes were lysed using the Immunoprep Reagent System
and a TQ-Prep Workstation (Beckman Coulter). To reduce
the background level of staining, lysed samples were washed
with 1.0 mL PBS, centrifuged for 3 min at 300 × g and fixed in
PBS/1% formalin. Specimens were routinely analyzed for immunofluorescence on a BD FACSCalibur (BD Bioscience) using a
manually determined scattergate to gate lymphocytes. Absolute
lymphocyte counts on blood specimens were obtained using an
ADVIA 120 Hematology Analyzer (Siemens Medical Solutions
USA, Malvern, PA, USA).

Biophysical Characterization of
MM IgG Recognition by Human FcγR

The ability of the high affinity human FcγRI to recognize each
MM subclass was determined in a multiplex assay that quantified
IgG bound to FcγR-conjugated fluorescently coded microspheres.
The high affinity human FcγRI receptor was observed to favor
MM IgG1 > IgG2 > IgG3 and IgG4 (Figure 2A), in contrast to
human IgGs, which are favored as IgG1/IgG3 > IgG4 > IgG2 (11,
39). The interaction between MM IgG and FcγRI was found to be
highly dependent on IgG glycosylation (Figure 2B). Complete
removal of N-linked IgG glycans with PNGase F ablated FcγRI
recognition and glycan restriction with the IgG glycosidase
EndoS, which leaves a core GlcNac that is variably fucosylated,
likewise compromised binding.
Significant glycosylation sensitivity was also observed for the
low affinity FcγRII and FcγRIII receptors using the multiplexing
assay, where EndoS treatment significantly reduced the binding
of MM IgG1 to FcγR-conjugated beads (Figure 3A). Glycan
dependence was probed when IgG multimers were present in
the antibody preparations to facilitate binding and indicated that
glycan was necessary for recognition of even multimeric IgG.
Similar results were observed following treatment with PNGaseF
and across all MM subclasses and polyclonal serum IgG (data not
shown). While the glycosylation profiles of CHO-derived MM
IgG subclasses were relatively uniform and dominated by fucosylated non- and mono-galactosylated (G0F and G1F) species,
serum-derived MM IgG exhibited a considerably more complex
glycoprofile including many peaks comprised of sialylated glycoforms (Figures 3B,C).
To characterize the affinity of monomeric MM IgG subclasses and rhesus serum-derived polyclonal IgG toward human
FcγRII and FcγRIII receptors, a series of label-free kinetic
experiments was conducted. Importantly, the use of SPR for
this purpose offers greater sensitivity in characterizing low
affinity interactions and enabled evaluation without reliance
on detection reagents, which have the potential to introduce
confounding factors. Indeed, the anti-CH1 reagents commonly
employed to immobilize antibodies reliably maintained association to some but not all MM IgG subclasses, and therefore

RESULTS
Sequence and Structural Differences
among IgG Subclasses

The four IgG subclasses known to be present in MM were aligned
with the CH2 domain of human IgG subclasses. Annotation
of FcγR contact residues from co-crystal structures available
for the high affinity FcγRI (35), low affinity FcγRIIa (36), and
FcγRIIIa (37, 38) (Figure 1A) suggests that most MM IgG
types are most similar to human IgG1 among predicted contact
residues. As captured in a sequence identity matrix (Table 1),
MM IgG were generally more similar to each other than to any
human subclass. Thus, subclass numbering between species is
not strictly consistent with overall sequence similarity between
species across the entire Fc domain; further, rhesus subclasses
tended to be more similar to human IgG1 than any other human
subclass within the CH2 region responsible for recognition by
FcγR. This sequence comparison suggests that MM IgG may
function most similarly to human IgG1 and implies they may
not exhibit the broad range of effector activities present among
human IgG subclasses.
When sites of sequence variation between human and MM
IgG1 are plotted on a rendering of the Fc–FcγR co-crystal
structure, it is similarly apparent that most of the substitutions between species are located distal to FcγR contact residues
(Figures 1B,C). One notable exception is H38, which borders
an FcγR contact residue and is substituted to Q in all MM subclasses. In contrast, across the human IgG subclasses, a number
Frontiers in Immunology | www.frontiersin.org
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Figure 1 | Sequence and structural differences between human and Macaca mulatta (MM) immunoglobulin G (IgG). (A) Sequence alignment of human
IgG subclasses with the recombinant monoclonal rhesus macaque IgG. CH2 and CH3 domains are denoted in gray, whereas the N-linked glycosylation site and
known human IgG Fc gamma receptors (FcγR) contact residues (35–38) are annotated in blue. (B) Structural model of human IgG1 CH2 and CH3 domains (ribbon)
in complex with human FcγRIIIa extracellular domain (space-fill) in which amino acids that differ between rhesus and human IgG1 sequences for each species are
colored orange (pdb 1T89). H38Q and oligosaccharides at N297 are illustrated in ball and stick. (C–E). A top-down view of the FcγR binding site, in which
conserved positions are colored blue and variant positions colored orange. Oligosaccharides at N297 are illustrated in ball and stick. (C) Positional variance in the
FcγR contact interface between human and MM IgG1. (D) Positional variance in the FcγR contact interface among the human IgG subclasses. (E) Positional
variance in the FcγR contact interface among MM IgG subclasses. (F) Structural model of human IgG1 (ribbon) in complex with human FcγRIIIa (space-fill) in which
amino acids that differ between MM IgG subclasses are colored orange. H38Q is illustrated in ball and stick.

Composition and Properties of Polyclonal
MM Serum IgG

antibodies were covalently conjugated directly to SPR chips.
The mean binding affinities (KD) for MM IgG subclasses
across human FcγR allotypic variants were determined by
global fitting of kinetic data using a 1:1 model (Table 2),
and representative curve fits are shown in Figure 4. FcγRIII
variants showed a strong preference toward MM IgG1 relative
to all other subclasses, whereas FcγRII variants exhibited less
variable affinities across MM subclasses. Notably, a sample of
purified polyclonal serum IgG exhibited binding affinities with
good agreement to MM IgG1.

Frontiers in Immunology | www.frontiersin.org

To further evaluate whether the recombinantly produced MM
IgGs reflected the behavior of naturally derived plasma IgG
secreted by B cells, we conducted SPR experiments on a set of purified polyclonal antibodies from 10 MM (Figure 5B). Consistent
with the commercially available preparation in Figure 5A,
natural IgG exhibited an FcγR-binding profile highly consistent
with MM IgG1, suggesting that MM serum IgG may be predominantly comprised of IgG1 or allotypic variants of other subclasses
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A limited number of studies report use of subclass-specific
detection reagents (40). We evaluated a set of α-MM IgG subclass
detection reagents for their subclass specificity and sensitivity.
In a multiplex assay, we observed that IgG2 and IgG3 could be
reliably distinguished from other recombinant subclasses using
detection reagents raised against their hinges (Figure 6A), but
that the available α-MM IgG1 detection antibody exhibited some
cross-reactivity with MM IgG3. No detection reagent for MM
IgG4 was available. Similar results were observed when these
subclass detection antibodies were used in an ELISA format to
detect recombinant CD8α-specific MM IgG bound to plates
coated with CD8α (Figure 6C).
When these detection reagents were used to characterize the
subclass composition of plasma IgG across a set of 36 MM serum
IgG samples in a multiplexed fluorescent microsphere assay,
only low levels of IgG2 or IgG3 were observed (Figure 6B). To
understand the sensitivity limits of these reagents, analysis of
defined mixtures of the recombinant monoclonals indicated that
IgG2 and IgG3 could be detected even when prevalent at less than
10% by mass. When these reagents were used in ELISA format to
detect MM subclasses from recombinant mAbs and polyclonal

with IgG1-like FcγR binding. While IgG mixtures with different
fractionation profiles have been resolved chromatographically
(6), a general understanding of the subclass composition of MM
plasma IgG has been lacking.
Table 1 | Relative Fc sequence conservation across species.
MM IgG1

MM IgG2

MM IgG3

MM IgG4

CH1–hinge–CH2–CH3
Hu IgG1
90.7
Hu IgG2
87.1
Hu IgG3
78.5
Hu IgG4
87.4
MM IgG1
–

88.5
88.3
76.4
87.2
89.8

89.2
87.7
78.2
89.2
91

88.8
88.1
76.4
90.2
89.2

CH2
Hu IgG1
Hu IgG2
Hu IgG3
Hu IgG4
MM IgG1

89.1
84.5
87.3
86.4
90.9

90.9
88.2
89.1
91.8
92.7

92.7
90.0
90.9
93.6
90.9

90.0
82.7
87.3
85.5
–

Matrix presents the percent identity between the entire Fc and within the CH2 domain
only.

Figure 2 | Recognition of Macaca mulatta (MM) immunoglobulin G (IgG) by human FcγRI. (A) Recombinant monoclonal rhesus macaque IgG (MM
IgG1–4) with minor contamination with dimeric IgG and purified polyclonal rhesus macaque plasma IgG (MM pIgG) were titrated for binding to the high affinity
human FcγRI. Triplicates representative of two independent experiments are presented. (B) IgG samples were treated with PNGaseF (blue) or EndoS (red) to remove
either all or all but the variably fucosylated GlcNac core of the Fc domain glycan. Triplicate dilutions are presented.

Figure 3 | Glycosylation state of Macaca mulatta (MM) immunoglobulin G (IgG) and glycan requirement for binding to low affinity human FcγR. (A)
Recombinant monoclonal rhesus macaque IgG (MM IgG1–4) with minor contamination with dimeric IgG and purified polyclonal rhesus macaque plasma IgG (MM
pIgG) were either untreated or treated with EndoS (red) leaving a variably fucosylated GlcNac core of the Fc domain glycan. Triplicate measurements at 5 × 10−7 M
MM IgG1 in one representative multiplex assay are presented. (B,C) IgG glycosylation as determined by glycan HPLC for MM IgG1 (B) and polyclonal IgG derived
from MM serum (C). Peak identities were determined by exoglycosidase digests and glycan controls.
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Table 2 | Affinity of Macaca mulatta (MM) immunoglobulin G (IgG) subclasses for low affinity human FcγR.
FcγR
Experiment 1

Experiment 2

FcγRIIa H131
FcγRIIa R131
FcγRIIb/c
FcγRIIIa V158
FcγRIIIa F158
FcγRIIIb NA1
FcγRIIIb NA2
FcγRIIIb SH
FcγRIIa H131
FcγRIIa R131
FcγRIIb/c
FcγRIIIa V158
FcγRIIIa F158
FcγRIIIb NA1
FcγRIIIb NA2
FcγRIIIb SH

MM IgG1

MM IgG2

MM IgG3

MM IgG4

7±1
9±4
36 ± 7
4±2
4±1
18 ± 7
13 ± 5
15 ± 8
9±2
21 ± 9
53 ± 14a
5±2
8±2
14 ± 6
15 ± 3
9±4

11 ± 4
32 ± 7
90 ± 43a
21 ± 13
48 ± 51a
700 ± 430a
400 ± 420a
530 ± 340a
11 ± 4
41 ± 16a
125 ± 37a
14 ± 11
15 ± 4
250 ± 320a
32 ± 2a
80 ± 100a

27 ± 9
11 ± 2
46 ± 12a
84 ± 84a
78 ± 52a
700 ± 430a
510 ± 370a
740 ± 370a
16 ± 4
25 ± 20
38 ± 7
27 ± 33
33 ± 4a
210 ± 170a
270 ± 420a
350 ± 860a

23 ± 5
11 ± 2
33 ± 3
32 ± 11a
48 ± 26a
500 ± 370a
730 ± 380a
465 ± 400a
20 ± 10
20 ± 6
32 ± 7a
29 ± 17
17 ± 1
120 ± 80a
270 ± 67a
340 ± 500a

Binding affinities (KD) of MM IgG subclasses for low affinity human FcγR allotypic variants as determined by surface plasmon resonance. Data are reported as the mean in
micromolar ± SD across at least three independent measurements.
a
Value is outside of the concentration range used and is therefore less reliable.

Figure 4 | Representative surface plasmon resonance (SPR) data and curve fits. Raw SPR signals (black) and kinetic curve fits (red) in a 1:1 model are
presented for the Macaca mulatta immunoglobulin G (IgG) subclasses and a purified serum IgG sample for FcγRIIa H131 and FcγRIIIb SH allotypes.

sera adhered to plates, IgG2 and IgG3 could be detected above
background in the single polyclonal sera sample evaluated in
this format (Figure 6D). Using absorbance signal to estimate
concentration, however, indicated that IgG2 and IgG3 are likely
minor components.
We next sought to assess IgG subclass concentrations in serum
using semi-quantitative mass spectrometry. Manual inspection
of the IgG subclass protein sequences suggested that subclassunique tryptic peptide sequences could be used to both confirm
the identity of individual subclasses within mixed samples or
serum, as well as quantify the relative abundances in these
samples. To do so, recombinant purified IgG subclasses were
analyzed as pure samples as well as diluted in known ratios to
one another to produce mixed IgG samples for development of
a standard curve. These mixed standards were then separated
by SDS-PAGE, digested with trypsin, and analyzed by high
performance mass spectrometry. Unique peptide sequences were

Frontiers in Immunology | www.frontiersin.org

identified for all subclasses except IgG3; the peptide sequence
that uniquely identifies this subclass is large and hydrophobic,
which precluded its routine analysis from these mixtures. For the
remaining three subclasses, peptide peak area standard curves
were generated as a fraction of the total IgG analyzed, which
enabled linear regression-based quantification of IgG subclasses
1, 2, and 4 from macaque sera (Table 3). Consistent with results
noted above, IgG1 was the most abundant of the subclasses in
these samples, followed by IgG2 and IgG4. Although IgG3 was
unambiguously qualitatively identified in some of these serum
samples, the poor quantitative performance of its unique peptide
prohibited accurate estimation of its abundance.

Effector Function of MM IgG Subclasses

To assess the functional impact(s) of observed differences in FcγR
binding between MM subclasses, we next evaluated the activity
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THP-1 cells express a range of FcγRs, including FcγRI, FcγRIIa,
FcγRIIb, and sometimes FcγRIIIa, but phagocytic activity is most
tightly linked to FcγRII ligation with some contribution from
FcγRI (33, 41). In contrast to human IgG subclasses (Figure 8B),
which exhibit dramatically different phagocytic potencies, MM
IgGs demonstrated relatively consistent activity when either
the Fv target antigen CD8α (Figure 8C) or an anti-MM IgG
polyclonal antibody-based capture (data not shown) was used to
form immune complexes. This ADCP activity profile observed
was consistent with affinity for FcγRII by SPR. Differences in
phagocytic activity among MM subclasses were considerably
less pronounced than activity differences observed in the NK
activation assay (Figure 7B) or in phagocytosis activity among
human IgG subclasses (Figure 8B), which was assessed using an
anti-human Fab capture bead and myeloma-derived human IgGs
of approximately 90% purity.
Lastly, each anti-CD8α IgG representing the four rhesus
subclasses was passively administered to two rhesus macaques
at 50 mg/kg, and in vivo effector function was assessed by quantifying CD8+ T cells in blood. To avoid cross-blocking by the
administered anti-CD8α, CD8+ T cells were identified by whole
blood immunophenotyping as CD3+CD4−. The percent change
from baseline in the absolute number of targeted cells is shown
in Figure 9. Anti-CD8α antibodies of the IgG1 and IgG2 subclass
resulted in prompt loss of the targeted cell subset from blood to
<20% of baseline. The mean extent and duration of CD8+ T cell
depletion was greater in animals treated with IgG1 than with IgG2.
The extent of CD8+ T cell depletion in animals treated with IgG3
or IgG4 never less than 40% of baseline. Furthermore, the average
number of CD8+ T cells in animals treated with IgG4 exceeded
the baseline values after 2 weeks. Despite the similarities in FcγR
between species, the existence of several MM FcγR allotypic variants that strongly impact receptor recognition of antibody (42),
or have been implicated in differential intracellular signaling (43),
and the limited number of animals in this study precludes rigorous
differentiation of subclass activity profiles in vivo. However, this
depletion profile is nonetheless consistent with the biophysical
and in vitro functional assays, suggesting that MM IgG subclasses
rank by effector activity as IgG1 > IgG2 > IgG3/4. The striking
differences in depletion between subclasses appear most consistent with FcγRIII-mediated activity and suggest involvement of
NK cells.

Figure 5 | Affinity of rhesus immunoglobulin G (IgG) for low affinity
human FcγR. (A,B) Equilibrium binding affinity (KD in micromolar) of
recombinant monoclonal rhesus IgG subclasses [Macaca mulatta (MM)
IgG1–4] as well as a commercially supplied sample of purified polyclonal
rhesus macaque plasma IgG (MM pIgG) to the low affinity human FcγR. Bars
denote the mean of two to six replicates, in two separate experiments (upper
and lower panels) using different preparations of FcγR. (B) Equilibrium
binding affinity (KD in micromolar) of 10 randomly selected purified rhesus
macaque plasma IgG samples. Bars and whiskers denote the median and
interquartile range.

of each subclass in an assay measuring antibody-driven induction
of human NK CD107a surface expression via cross-linking of
FcγRIIIa V158, a surrogate indicator of NK cell cytokine release
(30), cytotoxicity (29), and ADCC (14, 31, 32). Subclass-switched
versions of a human mAb were able to induce NK activation
only in IgG1 and IgG3 forms (Figure 7A). In contrast, all MM
IgG subclasses were capable of activating the same preparation
of NK-92 cells (Figure 7B), though one experiment with less
responsive NK-92 cells more dramatically differentiated among
MM subclasses. Consistent with biophysical data, this functional
assessment demonstrated that MM IgG1 and serum-derived MM
pIgG exhibited the greatest induction of NK cell activity.
To evaluate the effector function of a phagocytic human effector cell with a more complex FcγR expression profile, we next
evaluated the activity of each subclass in a commonly utilized
assay of ADCP, in which monocytic human THP-1 cells are used
as effectors and their uptake of antibody-opsonized fluorescent
beads is quantified by flow cytometry (33). Beads were covalently
conjugated with CD8α, and the phagocytic activity of each MM
IgG subclass was determined across a titration range (Figure 8A).

Frontiers in Immunology | www.frontiersin.org

DISCUSSION
While the effector function of polyclonal, antigen-specific
antibodies elicited by candidate vaccines evaluated in NHP has
often been investigated and tested in vitro using human effector
cells (2, 5, 13, 15, 18, 44), surprisingly little is known about the
immunobiology of NHP IgG subclasses and their interaction
with human FcγRs. As evidence of the significance of Fc domaindriven effector functions to the in vivo activity of even antibodies
with highly potent Fv domains continues to accumulate (3,
45–48), and the relevance that divergent subclass distributions
in response to vaccination may play in efficacy in humans has
become more apparent (49–51), an improved understanding
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Figure 6 | Characterization of rhesus immunoglobulin G (IgG) subclass composition and detection reagents. (A,B) Multiplex subclassing assays. (A)
Recombinant monoclonal rhesus macaque IgG [Macaca mulatta (MM) IgG1–4] and pooled purified polyclonal rhesus macaque plasma IgG (MM pIgG) were titrated
for binding to microspheres conjugated with anti-MM, subclass-specific antibodies (anti-MM IgG1, anti-MM IgG2, anti-MM IgG3), and bound test antibody detected
by a pan anti-rhesus IgG detection antibody. (B) In a separate experiment, antibody purified from serum samples from 36 naïve MM (black) was likewise evaluated
to detect the presence of IgG1, IgG2, and IgG3 subclasses. (C,D). ELISA subclassing assays. (C) Sensitivity and specificity of MM subclass detection reagents over
a titration range when recombinant, CD8α-specific MM IgG subclass antibody test samples were bound to CD8α-conjugated ELISA plates. (D) The composition of
MM serum IgG in a pooled sample was evaluated via an ELISA in which either non-specifically adhered serum IgG or recombinant MM IgG subclasses as controls
were detected using a dilution series of the anti-subclass detection reagents.

induce lysis of opsonized B cells (11), while a previous study
evaluating cynomolgus subclasses indicated otherwise (10). One
confounding factor related to the existing literature regarding
NHP subclasses is that some cross-species comparisons evaluate
more identical sequences than within-species comparisons made
across studies that have apparently utilized different allotypic variants. These allomorphs could significantly impact study results,

of the correspondence of antibody biology between NHP and
humans is likely to facilitate translational efforts centered on this
model organism.
Previous studies have indicated that macaque IgG1 induced
both ADCC and phagocytosis, but that the sole macaque IgG2
evaluated could not (7, 52–54). In contrast, a recent study of
cynomolgus IgGs indicated that all subclasses were all able to
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Table 3 | Estimates of subclass prevalences in Macaca mulatta serum based on MS.
Animal
1
IgG1
IgG2
IgG3
IgG4

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

++++ +++++ ++++ ++++ +++ +++ ++++ +++ +++++ ++++ ++++ ++++ +++++ ++++ ++++ +++ ++++ +++ ++++
+
++
+
+
++
+
+
+
++
+
++
++
++
++
++
++++
++
+++
++
nd
nd
nd
nd
nd
nd
*
nd
*
nd
nd
nd
Nd
nd
*
nd
*
*
nd
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

Response magnitudes are characterized as follows: nd, not observed; *, not quantified; +, <20%; ++, 20–40%; +++, 40–60%; ++++, 60–80%; +++++, 80–100%.

Figure 7 | Characterization of natural killer (NK) cell degranulation activity of Macaca mulatta (MM) immunoglobulin G (IgG) subclasses and
comparison to human IgG subclasses. (A) Subclass-switched forms of the human VRC01 mAb were evaluated in for ability to drive degranulation of NK-92 cells
by directly coating a dilution series of IgG onto a 96-well plate. (B) Recombinant rhesus macaque IgG (MM1–4) and polyclonal rhesus macaque plasma IgG (pIgG)
was likewise evaluated. Results from an assay with less responsive (left, n = 1) or normally responsive NK-92 cells (right, n = 4) are presented.

Figure 8 | Characterization of the phagocytic activity of Macaca mulatta (MM) immunoglobulin G (IgG) subclasses and comparison to human IgG
subclasses. (A) Exemplary flow cytometry histograms for a titration of MM IgG1 driving phagocytosis of CD8α-conjugated fluorescent beads. (B) Myeloma-derived
human IgG1–4 were evaluated in the same assay measuring uptake of fluorescent beads, in this case using beads conjugated with an anti-human Fab reagent.
Results from one representative experiment with technical replicates are presented. (C) Recombinant monoclonal rhesus macaque IgG (MM IgG1–4) was evaluated
for its ability to drive phagocytosis of CD8α-conjugated fluorescent beads. Representative results from two of five independent experiments in which duplicate
titrations were assessed are presented.

and thus, given the limited information regarding the degree of
allotypic variation among NHP subclasses, caution regarding
universal application of statements as to subclass activity should
be maintained. Here, we evaluated a single allotype of each MM
subclass, from a widely available supply of recombinant protein,
with a well-documented sequence.
We found that compared to human IgG subclasses, the
MM subclasses tended to possess a more uniform binding and
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functional profile, with MM IgG1 generally exhibiting the highest
activity, followed by IgG2, then IgG3/IgG4. Importantly, the biophysical and functional characterization here was well-supported
by sequence and structural homology. Previous sequencing studies have posited that the MM IgG subclasses resulted from gene
duplication events subsequent to the evolutionary branchpoint
from humans based on the observation that MM subclasses are
more highly related to each other than to their nominal human
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associated with the observation that IgG3 responses were potentiated among uninfected RV144 vaccine recipients (50), or factor
into other candidate vaccine responses, they too may be difficult
to recapitulate in NHP models.
Though the MM IgG subclasses fail to provide exact correspondence to human IgG subtypes, the relatively more uniform
profile of MM IgGs likely has the advantage of potentially
reducing sources of variation that could otherwise significantly
impact antibody activity, the relative composition of plasma, or
antigen-specific responses. Interestingly, we found in SPR experiments conducted on 10 MM plasma IgG samples that macaque
serum IgG demonstrated affinity to FcγRs that were generally
most similar to recombinant MM IgG1. Assuming that glycan
and allotypic variance play a secondary role to subclass prevalence in FcγR-binding, this result implies that serum IgG may be
predominantly comprised of the IgG1 subclass. Consistent with
this possibility, but subject to limitations in detection of reagent
availability and sensitivity, we observed only limited detection of
IgG2 or IgG3 from two sets of MM serum IgG samples, though it
is possible that allotypic variance in the IgG hinge region recognized by the anti-subclass detection reagents or other differences
between naturally derived and recombinant MM IgG may also
confound the ability to detect MM IgG subclasses. MS-based
analysis of the subclass composition of serum IgG indicated that
IgG1 was the predominant species in 18/19 animals, but levels of
IgG2 estimated from standard curves accounted for an average
of ~25% of serum immunoglobulin, which, based on results with
mixtures of defined proportions of recombinant IgG, would have
been expected to be easily detected with the subclassing reagents.
Thus, while these data are not completely conclusive regarding
the subclass composition of rhesus IgG, it is consistent with previous findings: a prior study found that 13 of 14 mAbs produced
by rhesus heterohybridomas were consistent with IgG1, while
only 1/14 was identified as an IgG2 based on restriction digests
(7). In studies using RT-PCR, relative transcript expression levels
were observed as follows: IgG1 > IgG2 > IgG3 > IgG4 (9); while
gel-based quantitation of cDNA amplification of the hinge region
indicated a relative prevalence of IgG1 >> IgG3 > IgG2 (7).
Indeed, in several earlier studies, transcripts of the IgG4 subclass
were not observed (7, 60).
While this study does not address potential differences in
MM IgG activity due to differences in MM FcγR, our characterization of these receptors suggests that they generally exhibit
similar binding preferences as human FcγR (42). However, some
allotypic variants bear reduced ability to bind IgG. Additionally,
some MM FcγR allotypes vary in their intracellular domains, and
one of these differences was previously associated with more or
less complete B cell depletion using rituximab (43). Furthermore,
little is known about MM FcγR expression levels or distribution
on innate immune cell subsets, which could drive dramatic differences in their activity in vivo as compared to human effector
cell types.
Overall, we find that consistent with inferences from sequence
and structural models, rhesus macaque IgG subclasses exhibit
relatively uniform FcγRI and FcγRII binding and phagocytosis
activity profiles—often in contrast to their nominal human IgG
counterparts, which exhibit significantly greater structural and

Figure 9 | In vivo administration of anti-CD8α antibodies representing
the four rhesus immunoglobulin G subclasses. A single 50 mg/kg dose
of each antibody was administered IV to two normal rhesus macaques, and
the change from baseline in absolute number of CD3+CD4− lymphocytes in
blood was assessed. Each data point represents the average (n = 2) percent
change from baseline (average of two pretreatment measurements).

counterparts (7, 9). Sequence conservation among FcγR contact
residues further supports the observations made here and in
studies of cynomolgus macaque subclasses that IgG types may
be rather more uniformly active in NHP than humans (11, 55).
The biophysical features of IgG subclasses have likely evolved
differently between species in part due to differences in the selective pressures individual species are exposed to in their natural
environments. In particular, differences in immunological strategies addressed at bacteria, parasites, and allergens, against which
humans often engender IgG2- and/or IgG4-biased responses
(56–59), and even potential differences in the importance of amelioration of autoimmune or allergic responses, which are often
associated with subclass switching to IgG4 in humans, between
species, are suggested by these activity differences.
Notably, a series of studies have evaluated the significance of
differences in IgG subclass selection on the activity and potential
mechanistic link to efficacy in human HIV vaccine studies (49–51).
Because rhesus macaques are the most frequently used preclinical
model in HIV vaccine evaluation, there has been significant interest in understanding whether differential induction of subclasses
is also associated with vaccine efficacy in macaques. However,
together with evaluation of cynomolgus IgG subclasses (11), our
study finds that the repertoire of antibody FcγR-binding activities
present in humans is imperfectly matched to those in NHP. The
more functionally inert human IgG2 and IgG4 subclasses are evidently not well mirrored among NHP subclass variants; and the
functionally potentiated human IgG3 subclass bears little structural similarity to any known NHP IgG type. While human IgG1
and IgG3 demonstrate relatively similar affinities across FcγR,
human IgG3 has often been observed to demonstrate superior
activity in cell-based functional assays. These observations may
be linked to the unique architecture of the human IgG3 hinge,
which is considerably longer, bears different disulfide bonding
structure, and is differentially flexible than other subclasses in
humans. To the extent that these features may be mechanistically
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functional diversity. MM IgG1 exhibited preferential binding for
human FcγRIII receptors and accordingly displayed the greatest
activation of NK cells among the MM subclasses. Consistent with
biophysical and cell-based assays, and suggestive of the importance of NK-mediated ADCC, passively administered anti-CD8α
MM IgG1 supported the most robust depletion of CD8+ T cells
in vivo, whereas depletion by IgG2 was moderate, and IgG3 and
IgG4 demonstrated only modest (IgG3) and/or transient (IgG4)
reduction.
Though previous studies have aimed to characterize the induction of specific IgG subclasses among vaccinated rhesus macaques
(61, 62), collectively, the findings in this study suggest that the
functional differences associated with subclass-switching profiles
observed in human HIV vaccines cannot be strictly recapitulated
in NHP vaccine studies. Accordingly, care must be taken not to
presume the significance of “nominal” correspondence of subclass
types. Finally, they also indicate that regulation of the posttranslational glycosylation of the Fc domain may play a significant role
in dictating some MM IgG activities, and that glycoprofiling of
vaccine-induced antibody responses could be a valuable indicator
of antibody activities across species. While greater understanding
of FcγR allotypes and expression patterns represent additional
critical factors in developing a better understanding of the correspondence of antibody biology between species, identification
of the similarities and dissimilarities between IgG subclasses is an
important step to enabling both effective translation of findings in
NHP studies into the clinic and the investigation of clinical correlates observed in human studies in these key model organisms.
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